Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.03
-0.01 (-0.14%)
Apr 28, 2026, 2:39 PM EDT - Market open
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $181.4 million as of April 28, 2026. Its market cap has increased by 309.12% in one year.
Market Cap
181.40M
Enterprise Value
94.88M
1-Year Change
309.12%
Ranking
Category
Stock Price
$7.03
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $181.40M, a decrease of -78.79%. That is a compound annual growth rate of -19.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 181.65M | 81.40% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 193.20M |
| Sagimet Biosciences | 190.95M |
| Whitehawk Therapeutics | 190.20M |
| Korro Bio | 185.91M |
| Acumen Pharmaceuticals | 185.59M |
| Unicycive Therapeutics | 183.98M |
| Tonix Pharmaceuticals Holding | 179.13M |
| Cartesian Therapeutics | 178.94M |